Financhill
Back

Minerva Neurosciences 10K Form

Sell
33

NERV
Minerva Neurosciences

Last Price:
2.53
Seasonality Move:
30.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NERV News And Ratings

See the #1 stock for the next 7 days that we like better than NERV

NERV Financial Statistics

Sales & Book Value

Annual Sales: $41.18M
Cash Flow: $-5.99M
Price / Cash Flow: 0
Annual Sales: $-4.07
Price / Book: 0

Profitability

EPS (TTM): -4.66000
Net Income (TTM): $-30.01M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Minerva Neurosciences Earnings Forecast

Key Minerva Neurosciences Financial Ratios

  • The Selling, General & Administrative Expenses for NERV have been equal to 41.99% of Gross Profit Margin.
  • The Interest Expense is -27.60% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Minerva Neurosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: NERV
CUSIP: 603380
Website: minervaneurosciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NERV Technical Analysis vs Fundamental Analysis

Sell
33
Minerva Neurosciences (NERV) is a Sell

Is Minerva Neurosciences a Buy or a Sell?